SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-16-000078
Filing Date
2016-05-03
Accepted
2016-05-03 17:03:32
Documents
76
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2016q110-q.htm 10-Q 1188543
2 EXHIBIT 3.1 a2016q110-q_exhibit31.htm EX-3.1 106618
3 EXHIBIT 31.1 a2016q110-q_exhibit311.htm EX-31.1 14546
4 EXHIBIT 31.2 a2016q110-q_exhibit312.htm EX-31.2 14380
5 EXHIBIT 32.1 a2016q110-q_exhibit321.htm EX-32.1 11771
  Complete submission text file 0000875320-16-000078.txt   7468845

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrtx-20160331.xml EX-101.INS 1805237
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20160331.xsd EX-101.SCH 56373
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20160331_cal.xml EX-101.CAL 83594
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20160331_def.xml EX-101.DEF 263992
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20160331_lab.xml EX-101.LAB 689069
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20160331_pre.xml EX-101.PRE 400967
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 161616299
SIC: 2834 Pharmaceutical Preparations